Decision Counseling and Follow-up for Shield+ Patients

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
Guardant Health, Inc.
Study ID
NCT07620535
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Colo-rectal Cancer

Eligibility Criteria

Sex
ALL
Age
45 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • Decision Counseling Session — BEHAVIORAL
    During the decision counseling session, JH research staff will review the Complete Diagnostic Evaluation (CDE) infographic and use an online survey to guide the participant through a telephone encounter that involves the identification of patient goals that are likely to affect their decision to have CDE and not to have CDE.

Study Details

Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.

Key Dates

Start date
Jun 30, 2026
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
350 participants (estimated)

Arms

  • Arm: SHIELD Positive with Completed Colonoscopy
    Patients who are intending to undergo a complete a diagnostic evaluation

Primary Outcome Measure

CDE Decisional Conflict [ Time Frame: From Enrollment to the end of study at 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Jefferson CenterPhiladelphiaPennsylvania19114
Principle Investigator
[email protected]
215-503-4085

Find similar trials in Philadelphia, PA

By research site
Jefferson Center· Philadelphia, PA

Related Studies